As the Q2 earnings season wraps, let’s dig into this quarter’s best and worst performers in the property & casualty insurance ...

That largely depends on the company's ongoing clinical development, and one of its candidates in particular, zenagamtide, ...

As the Q2 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the ...

American Ratings Corporation, the creator of Diamond Certified Resource, the source for consumers who love quality local companies, has published a new article on diamondcertified.org titled, "Paid ...

On Sept. 25, 2026, analysts weighed in, with BNP Paribas cutting its price target to $268, keeping investor focus on ...

PepsiCo plans to raise prices on some chips, sodas and dips. Here's when consumers can expect to see the cost increases.

One company has sticky government contracts, improving margins, and a growing backlog. The other has working quantum hardware ...

MIAMI--On September 25, 2026, the Fairholme Focused Income Fund ("FOCIX" or the "Fund") distributed an Ordinary Income dividend of $0.05297 per share to shareholders of record as of September 24, 2026 ...

On Sept. 25, 2026, the analyst firm slashed its price target to $30 from $47, citing weak wholesale momentum and China sales challenges.

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Texas Pacific Land (NYSE:TPL) ...

Six oral presentations and two posters will highlight Decipher’s prognostic and predictive value in identifying patients’ risk of progression and likelihood of benefiting from treatment ...

Eli Lilly and Company (NYSE: LLY) announced today that the U.S. Food and Drug Administration (FDA) approved Olumiant (baricitinib), a once-daily pill, for the treatment of pediatric patients 12 years ...